2015
DOI: 10.1016/s2222-1808(15)60940-9
|View full text |Cite
|
Sign up to set email alerts
|

Study of the inhibition effect of ethanolic extract of mangosteen pericarp on atherogenesis in hypercholesterolemic rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
9
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 21 publications
2
9
0
Order By: Relevance
“…In the present study,lowest LDL levelwas obtained from treatment of MPEE at 9 weeks compared to control and orlistat. Mangosteen Pericarp Ethanolic Extracts (MPEE) has been previously reported in several studies to inhibit cholesterol formation process 19,29,30 .…”
Section: Discussionmentioning
confidence: 99%
“…In the present study,lowest LDL levelwas obtained from treatment of MPEE at 9 weeks compared to control and orlistat. Mangosteen Pericarp Ethanolic Extracts (MPEE) has been previously reported in several studies to inhibit cholesterol formation process 19,29,30 .…”
Section: Discussionmentioning
confidence: 99%
“…The ethanolic extract of mangosteen pericarp (800 mg/kg) in hypercholestromic rat improved lipid profile, decreased level of H 2 O 2 and the expression of NF‐κB, iNOS, maintained the expression of eNOS and reduced HIF‐1α that lead to decrease vasa vasorum angiogenesis. The formation of vasa vasorum in an arterial vessel helps in progression of atherosclerosis plaque, so the ethanolic extract of mangosteen pericarp through its anti‐oxidant and antiinflammatory actions can prevent atherosclerosis (Tanaka et al, ; Wihastuti et al, ; Wihastuti et al, ). Diet supplemented 1% cholesterol in rat with 5% of mangosteen hindered rise in plasma lipid, total cholesterol liver and decrease in plasma anti‐oxidant activity (Haruenkit et al, ; Leontowicz et al, ).…”
Section: Methodsmentioning
confidence: 99%
“…ICU is a unit in the hospital that provides special care to patients (Jang, Park, Kim, & Chang, 2018). Life-threatening conditions include trauma, heart disease, stroke and others (Burke et al, 2013;Wihastuti, Widodo, Heriansyah, & Sari, 2015). WHO states that of the 56.9 million people who died in 2016, stroke and ischemic heart disease were the highest causes of death in the world, which reaches nearly 15.2 million people (WHO, 2018).…”
Section: Introductionmentioning
confidence: 99%